Simona Biosystems

Executive Summary

Simona Biosystems is a Copenhagen-based private company founded in 2018 that combines cutting-edge artificial intelligence with molecular dynamics simulations to unlock atomic-level insights into biological processes. The company's interdisciplinary team of experts and innovators focuses on developing AI-driven tools to accelerate molecular research, with potential applications in drug discovery, protein engineering, and materials science. Although specific financial details, stage, and total funding are not publicly disclosed, the company's niche at the intersection of AI and molecular dynamics positions it in a rapidly growing market. Simona's early-stage profile and lack of disclosed partnerships or revenues suggest it is still in the R&D phase, but its specialized focus and European base may attract interest from pharma and tech investors seeking AI-native biotech solutions.

Upcoming Catalysts (preview)

• H2 2026Publication of AI-Molecular Dynamics Model in Peer-Reviewed Journal60% success
• 2026Strategic Partnership with Pharmaceutical or Biotech Company40% success
• 2027Series A Funding Announcement50% success